First experiments on radioimmunodetection with b-12-monoclonal antibody fragments against breast cancer antigen.
In 14 patients with breast cancer the results of radioimmunoscintigraphy with 123I-labeled b-12 monoclonal antibody fragments were correct in more than two thirds of the patients.